Lumiera Health appoints Jacqueline Khayat to board of directors
by CM Staff
The company's board has granted an incentive stock options to Mrs. Khayat, entitling the purchase of an aggregate 300,000 common shares at a per share price of $0.05 for a period of 10 years.
MONTREAL — Lumiera Health Inc. has announced that Jacqueline Khayat will join the company’s board of directors.
“As previously announced, we are executing the first phase of our U.S. expansion and we are very excited to have Ms. Khayat join the board as we move into the next phase of our plan. Her experience launching brands in the U.S. will be a great asset to the team,” said Carlos Ponce, CEO of Lumiera Health in a statement.
“Ms. Khayat brings more than 20 years of combined experience in sales, business development, strategy, and M&A in the health & wellness sector.”
Ms. Khayat’s past experiences includes leadership positions at Neptune Wellness Solutions where she led the development and launch of several of the company’s consumer product brands in the United States and other markets.
Ms. Khayat holds a bachelor’s degree in Science with a Nutrition major from the Faculty of Medicine of Montreal University. She also holds a Graduate Degree in Management from HEC Montreal and an Executive MBA from the John Molson School of Business.
The company’s board has granted an incentive stock options to Mrs. Khayat, entitling the purchase of an aggregate 300,000 common shares at a per share price of $0.05 for a period of 10 years.
